These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25036261)

  • 21. Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Curr Hematol Rep; 2006 Mar; 5(1):95-9. PubMed ID: 16537053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Ogawa Y; Nagata T; Akiyama T; Nishida K; Kumasawa J; Kohno M; Kohata H; Gohma I
    J Thromb Thrombolysis; 2020 Nov; 50(4):1012-1014. PubMed ID: 32780355
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical evaluation of MD-805].
    Matsuo T
    Rinsho Byori; 1987 Sep; Spec No 73():150-60. PubMed ID: 3437530
    [No Abstract]   [Full Text] [Related]  

  • 25. Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban.
    Haas S; Lewis B
    Int Angiol; 2011 Dec; 30(6):541-6. PubMed ID: 22233615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.
    Edwards JT; Hamby JK; Worrall NK
    Ann Thorac Surg; 2003 May; 75(5):1622-4. PubMed ID: 12735590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia.
    Suzuki S; Sakamoto S; Koide M; Matsuo M; Fujii K; Matsuo T
    Thromb Res; 1997 Dec; 88(6):499-502. PubMed ID: 9610961
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.
    Beyer J; Halbritter K; Weise M; Leonhard J; Schellong S
    Thromb Haemost; 2007 Aug; 98(2):470-2. PubMed ID: 17721634
    [No Abstract]   [Full Text] [Related]  

  • 29. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F;
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
    Matsuo T; Wanaka K
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):459-64. PubMed ID: 18160571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.
    Tanimura K; Ebina Y; Sonoyama A; Morita H; Miyata S; Yamada H
    J Obstet Gynaecol Res; 2012 Apr; 38(4):749-52. PubMed ID: 22380425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argatroban in adult extracorporeal membrane oxygenation.
    Johnston N; Wait M; Huber L
    J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    Athar U; Husain J; Hudson J; Lynch J; Gajra A
    Am J Hematol; 2008 Mar; 83(3):245-6. PubMed ID: 17910040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenging Argatroban Management of a Child on Extracorporeal Support and Subsequent Heart Transplant.
    Latham GJ; Jefferis Kirk C; Falconer A; Dickey R; Albers EL; McMullan DM
    Semin Cardiothorac Vasc Anesth; 2016 Jun; 20(2):168-74. PubMed ID: 26721808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 38. Argatroban therapy in heparin-induced thrombocytopenia.
    Sparks ML
    AACN Adv Crit Care; 2009; 20(1):37-43. PubMed ID: 19174636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK; Baron SJ; Hursting MJ; Anglade E
    J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.